Prof David Vetrie and team have identified two “routes” (TR1 & TR2) leading to CML - helping explain differences in patient outcomes. 💡 Now, with a second Project Grant, the team is building on this to develop more targeted therapies. 🧡 Read more: www.leukaemiauk.org.uk/the-road-to-...

For many people with leukaemia, a diagnosis comes after months or even years of not being taken seriously by healthcare professionals.‼️ Tell the Government to end the delays in leukaemia diagnosis. For people like Jade, who have to fight to be heard: action.leukaemiauk.org.uk/end-the-delay

We are delighted to announce further funding for ground-breaking research through our 2026 Project Grants. 🔬 Applications are now open and will close at midday on 8th July 2026. Find out more and apply here 👉 leukaemiauk.org.uk/research-and-advocacy/research-funding-opportunities/project-grants

It took FOUR years and hundreds of visits to healthcare providers before Virginie was finally diagnosed with leukaemia. 🤯 Add your name and tell the Government to end the delays in leukaemia diagnosis: action.leukaemiauk.org.uk/end-the-delay

A simple full blood count would have diagnosed Mooni earlier and saved his family the horrendous torture of not knowing if he would ever wake up. Join over 7,000 people in calling for the Government to end the delays in leukaemia diagnosis 👉 action.leukaemiauk.org.uk/end-the-delay

For the first time, leukaemia has been recognised in the Government’s National Cancer Plan. That recognition matters. But action is what saves lives. Add your name and tell the Government to end the delays in leukaemia diagnosis: action.leukaemiauk.org.uk/end-the-delay #CountUsIn

Dr Kevin Rattigan, one of our funded researchers, has developed protein-based drugs called enzymes which can be used to starve leukaemia cells of some of the key nutrients they need to survive. 🎥 We caught up with Dr Rattigan in the lab to see how his research is going.

It shouldn’t have to take months of GP visits for leukaemia patients like Tracey to be taken seriously. But sadly, right now, this is their reality. 💔 Add your name and tell the Government to end the delays in leukaemia diagnosis: action.leukaemiauk.org.uk/end-the-delay

We were delighted to present our work on the first Best Practice Timed Pathway for blood cancers at @bsochaem.bsky.social conference. 🩸 This step-by-step guide - developed with @lymphomaaction.bsky.social @myelomauk.bsky.social and @england.nhs.uk - will improve diagnosis for blood cancer patients.

Ian saw his GP twice but wasn’t taken seriously. He was eventually diagnosed with acute myeloid leukaemia (AML) at A&E. Like Ian, 1 in 4 people with leukaemia face delays in diagnosis. Add your name to end the delays: action.leukaemiauk.org.uk/end-the-delay #AMLWorldAwarenessDay #CountUsIn

No one should have to fight to be heard. But like Jade, 1 in 4 people with leukaemia face avoidable delays in their diagnosis. It’s time to end the delays. Add your name and call on the Government to act: action.leukaemiauk.org.uk/end-the-delay #CountUsIn

📢 A new treatment has been approved on the NHS in Scotland for chronic lymphocytic leukaemia (CLL). Acalabrutinib, in combination with Venetoclax, has been approved by NICE for adults with previously untreated CLL. We are so pleased to have supported in this process. 🧡

📢 Have you been diagnosed with, or are you supporting someone with, acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS)? Would you be interested in taking part in a study which aims to improve access to stem cell transplants? Find out more: www.birmingham.ac.uk/research/pro...

Even when treatment seems to work, some people relapse. A new study suggests why 👇 Doctors already track tiny traces of cancer (MRD), but this research shows genetic changes in remaining cells also matter. 🔬 www.nature.com/articles/s41...

Exciting progress in blood cancer research! New AI tools are showing real promise in helping detect conditions like leukaemia more quickly and accurately from simple blood smears. 🩸 Read more about the research. 👇 www.nature.com/articles/s41...

Can you believe computer simulations can help to answer some of the questions behind why certain blood cancers relapse? 🩸 Dr Simon Mitchell @sussex.ac.uk, the latest recipient of our John Goldman Fellowship Follow-up Fund, is doing exactly this. Read more: www.leukaemiauk.org.uk/research-and...

Raising awareness of leukaemia within the deaf and hard of hearing community. 🧡 We teamed up with @signhealth.bsky.social to spread the word about leukaemia, and the common signs and symptoms, this #SignLanguageWeek.

Thanks to @leukaemiauk.bsky.social for helping to make it happen!

We were pleased to see The Rare Cancers Bill pass the Third Reading in the House of Lords last week. The Bill will help those with leukaemia and other rare cancers benefit from research, clinical trials and new treatments. Thank you @drscottarthurmp.bsky.social for bringing it to the House.

We’re delighted to announce further funding for healthcare professionals to undertake projects to improve treatment, care and quality of life for leukaemia patients. 🧡 Applications for our Patient Care Pioneer Award are now open. Find out more & apply: www.leukaemiauk.org.uk/research-and...

Have you ever heard of Graft-versus-host disease (GvHD) - a complication that can happen after a stem cell transplant? In our latest blog, we explore how and why it happens, how transplant teams try to reduce the risk, and how it can be treated. 👇 www.leukaemiauk.org.uk/stories/when...

Thank you @douglasmcallister.bsky.social for raising the issues of delays in diagnosing leukaemia. We are glad that @rthonwesstreeting.bsky.social recognises the issue and we're ready to work with the Government to ensure that the National Cancer Plan delivers for those affected by leukaemia.

🧬The Labour Government's National Cancer Plan will address unacceptable delays in leukaemia diagnoses, with 1/4 patients facing avoidable delays in being diagnosed. I asked the Minister how this will be implemented, with the historic introduction of genomic testing at birth. @leukaemiauk.bsky.social

Leukaemia patients in Wales face significant gaps in diagnosis, treatment and care. 🏴󠁧󠁢󠁷󠁬󠁳󠁿⚠️ The next Senedd MUST represent a moment of real change. We’re ready to work with the Welsh Government to stop leukaemia devastating lives. Read our report for Wales here: www.leukaemiauk.org.uk/app/uploads/...

Scotland has the power to transform the future for people with leukaemia. We're ready to work with the Scottish Government to turn the ambitious vision of the Scottish Cancer Strategy into progress for leukaemia patients. 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Read our report for Scotland here: www.leukaemiauk.org.uk/app/uploads/...

What does the Government’s new National Cancer Plan mean for people with leukaemia? In our latest blog, we take an in-depth look at the commitments that could transform diagnosis, treatment and care for leukaemia patients. 👇 www.leukaemiauk.org.uk/news/nationa...

📢 A huge win for #WorldCancerDay! The Government has announced a new metric to track early diagnosis for leukaemia, as part of the National Cancer Plan. We’ve campaigned for this commitment & will work to ensure it delivers for leukaemia patients. 🧡

With the National Cancer Plan set to be published tomorrow, our CEO Fiona Hazell sets out why the Government must urgently commit to earlier diagnosis targets for leukaemia - to improve outcomes and to save lives healthcaretoday.com/article/comm...

This week, the Government will launch its National Cancer Plan for England. We’re keeping you updated with the latest developments - including a £200m investment in local cancer care and greater access to trials for rare cancer patients - and our response. www.leukaemiauk.org.uk/news/latest-...

Could blocking a specific signalling pathway weaken AML cells and pave the way for new targeted treatments? Researchers have developed a drug designed to block key proteins found in Interleukin-1 (IL-1) - a signalling pathway relied upon by AML cells. 🔗 medicine.iu.edu/news/2026/01...

It was great to see the Rare Cancers Bill pass its Second Reading in the House of Lords last week. Thank you to Baroness Delyth Morgan for speaking about the poor survival rates for AML and raising the issues in leukaemia that the bill hopes to address. 🤞

Congrats to Dr Matthew Blunt & team on their latest publication, revealing findings which could help to treat autoimmune disease. 👏 A great example of how discoveries in blood cancer research can drive progress across other areas of medicine! ✨ academic.oup.com/cei/advance-...

We’re thrilled to hear that patients are already receiving Aucatzyl, a novel CAR-T therapy for B-ALL, less than a month after it was approved for use on the NHS. We’re proud to have advocated for its approval with @anthonynolan.bsky.social @leukaemiacare.bsky.social 🧡 www.bbc.co.uk/news/article...

Just incredible! Did you know that umbilical cord blood is rich in stem cells, and can be used for stem cell transplants - a crucial treatment option for many leukaemia patients? 🩸 www.bbc.co.uk/news/article...

A fascinating study by our co-funded researcher, Dr Katrin Ottersbach @edinburgh-uni.bsky.social, brings us closer to understanding why infant leukaemia is so hard to treat - and how future therapies might better target the disease. 🔗 www.exphem.org/article/S030...

A fantastic start to the year! Venetoclax with obinutuzumab has been approved on the NHS in England for people with untreated CLL, expanding access to a fixed-duration, targeted first-line treatment option. 👏

Are you enthusiastic about research and its potential to improve our understanding of leukaemia, develop kinder treatments and enhance patient care? Apply to be our next Research Manager 👉 www.leukaemiauk.org.uk/about-us/wor...

📢 Gentler, smarter and more personalised therapies are reshaping the future of leukaemia treatment and care. We took a deep dive into some of the key takeaways from this year’s American Society of Haematology (ASH) conference. 🩸 #ASH25 @ash.hematology.org www.leukaemiauk.org.uk/stories/rese...

Last week, we shared the fantastic news about BE-CAR7 - a world-first therapy using CRISPR technology to treat T-cell leukaemia. 🔬 But what exactly is CRISPR? How is it different from standard CAR-T therapy? And why is it such a big deal? 👇 www.leukaemiauk.org.uk/stories/rese...

It was a pleasure to attend @ash.hematology.org this week and learn about all of the promising advancements in leukaemia treatment and care - from gentler treatments for AML to next-gen CAR-T therapies. Look out for our upcoming blog for a deeper dive! #ASH25 🩸

A major breakthrough! A world-first therapy - BE-CAR7 - is using base-edited immune cells to treat T-cell acute lymphoblastic leukaemia (T-ALL) - one of the most aggressive and hardest-to-treat types of leukaemia. https://www.bbc.co.uk/news/articles/cj38ymeyg4mo

We are delighted to announce further funding into ground-breaking research in 2026, by continuing our investment in early career scientists & clinicians! 📢 Applications for our 2026 John Goldman Fellowships are now open. Find out more: www.leukaemiauk.org.uk/research-and...

📢 A significant step forward in expanding treatment options for B-ALL. We’re thrilled that Aucatzyl - a CAR-T cell therapy for treating relapsed or refractory B-cell acute lymphoblastic leukaemia - has been approved for use on the NHS in England. www.leukaemiauk.org.uk/news/leukaem...

How incredible is this?! Huge congratulations and a big thank you to Shaun and Salim, who completed the world’s most dangerous dive to raise funds for life-changing leukaemia research in memory of their friend, Trish. 🧡👏 www.express.co.uk/news/uk/2135...

The recipient of our 2025 Patient Care Pioneer Award: Dr Sarah Stapleton 🏆 Dr Stapleton will look at the psychological support that leukaemia patients might need, and develop a framework to help guide healthcare professionals. www.leukaemiauk.org.uk/research-and...

Major breakthrough for T-ALL! Researchers have identified a previously unknown subtype, which can be detected using routine tests. 👏 This means clinicians could soon pinpoint high-risk cases at diagnosis & personalise treatment for children with T-ALL. bioengineer.org/breakthrough...

This is deeply concerning. Early diagnosis is crucial for successful treatment in all cancers, including leukaemia, which is why we’re calling on the Government to commit to urgently tackling delays in early diagnosis in their upcoming National Cancer Plan. www.bbc.co.uk/news/article...

Last chance to share your views! How do you want to hear about the impact of your incredible support? We want to make sure that you’re the first to know about the life-saving research we’re funding, all thanks to you. 🧡 Have your say: https://survey.alchemer.eu/s3/90953656/a60c0b257002

Promising news! Researchers have found that statins, a cholesterol-lowering drug, could help to tackle “chemo brain” - a debilitating cognitive side effect for many cancer patients. 🤞 www.independent.co.uk/news/health/...

We want to hear from you - our fantastic supporters! How can we keep you informed about the impact of your incredible support, and how it’s helping us to fund life-changing leukaemia research? Fill in our short survey by midnight on Mon 10th Nov: survey.alchemer.eu/s3/90953656/...